BAFNA PHARMACEUTICALS
|
The Current P/S Ratio of BAFNA PHARMACEUTICALS is 1.73.
| Share Price | ₹107.5 | Mar 05,2026 |
| Market Cap | ₹254.8 Cr | |
| Sales-TTM | ₹147.4 Cr | TTM-Standalone Results |
| Price/Sales | 1.73x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BAFNA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹254.8 Cr] as on Mar 05,2026
(/) Sales [ ₹147.4 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.73x ]
Thus, for BAFNA PHARMACEUTICALS , the investors are currently willing to pay '1.73 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAFNA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of BAFNA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of BAFNA PHARMACEUTICALS
PS Ratio Performance Analysis for BAFNA PHARMACEUTICALS
- BAFNA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.44x.
- BAFNA PHARMACEUTICALS 's operated at median p/e ratio of 1.7x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAFNA PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 4.56x.
- BAFNA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 1.19x.
How does BAFNA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BAFNA PHARMACEUTICALS | 147.4 | 1.73 | 254.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.53 | 427,777.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.38 | 168,931.0 |
| CIPLA LTD | 28,351.1 | 3.78 | 107,112.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.56 | 147,330.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.16 | 109,593.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.60 | 91,867.7 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.53 | 92,015.1 |
| LUPIN LTD | 26,150.5 | 4.08 | 106,601.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.15 | 71,194.7 |
| ABBOTT INDIA LTD | 6,824.1 | 8.59 | 58,637.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAFNA PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.73x |
| Max industry PS | 16.38x |
| Median industry PS | 4.08x |
| Average industry PS | 6.28x |
You may also like the below Video Courses